Following the FDA’s emergency approval of Johnson & Johnson’s COVID-19 vaccine, ROI-NJ published a collection of health experts’ perspectives that includes institute director Richard Marlink’s comments about vaccine efficacy.
The dashboard, which displays information to help state residents, stakeholders, and policy makers understand the range of services available to youth and families, comes at a critical time. The pandemic continues to impact children and youth, who face increased levels of anxiety, stress, isolation, and a sense of loss and grief.
In an interview for WRSU Rutgers Radio, institute director Richard Marlink offers perspective on the importance of a global response to COVID-19, vaccine infrastructure in Africa, vaccine production and safety, and the World Health Organization.
The importance of a global COVID-19 vaccination strategy and how WHO involvement benefits the U.S. overall are topics that institute director Richard Marlink discusses in this Q&A.
Appearing on CNBC’s Power Lunch, core faculty member and Rutgers vice chancellor Reynold Panettieri discusses the Johnson & Johnson COVID-19 vaccine, infection rates and hospitalizations, and effective public health measures.
